A Cell-penetrating Antibody Fragment against HIV-1 Rev Has High Antiviral Activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Cell-penetrating Antibody Fragment against HIV-1 Rev Has High Antiviral Activity

Published:2014-07 Issue:29 Volume:289 Page:20222-20233
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Zhuang Xiaolei,Stahl Stephen J.,Watts Norman R.,DiMattia Michael A.,Steven Alasdair C.,Wingfield Paul T.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference42 articles.

1. Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy;McManus;PLoS One,2012

2. A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro;Levi;Proc. Natl. Acad. Sci. U.S.A,1993

3. A retro-inverso miniantibody with anti-HIV activity;Levi;AIDS Res. Hum. Retroviruses,2000

4. Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells;Monnet;J. Biol. Chem,1999

5. Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1;Bès;FEBS Lett,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines;European Journal of Pharmaceutical Sciences;2022-02

2. Discovery of Antivirals Using Phage Display;Viruses;2021-06-10

3. Intracellular Antibody Delivery Mediated by Lipids, Polymers, and Inorganic Nanomaterials for Therapeutic Applications;Advanced Therapeutics;2020-09-25

4. Targeting the undruggable: emerging technologies in antibody delivery against intracellular targets;Expert Opinion on Drug Delivery;2020-08-13

5. Antibody Delivery for Intracellular Targets: Emergent Therapeutic Potential;Bioconjugate Chemistry;2019-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3